immunity News and Research

RSS

More than 8 million people in the UK have taken COVID-19 booster vaccinations

Over eight million people have now received their COVID-19 booster jab, the latest figures show today (Monday 1 November 2021), ensuring the protection they've secured from their first two doses is maintained over the winter months.

1 Nov 2021

The effect of mass vaccination on COVID-19 mortality in Israel

A team of scientists from Israel and the USA has recently examined the efficacy of coronavirus disease 2019 (COVID-19) vaccination in reducing the death risk among people aged 70 years and above. They observe that despite government-imparted relaxation on non-pharmaceutical control measures, the vaccine saved more lives than expected by individual-level vaccine efficacy.

1 Nov 2021

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

A recent study published in the journal Cellular & Molecular Immunology shows that a new A.30 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can evade vaccine-induced antibodies and might spread outside the lungs extraordinarily well, with important implications for our public health response.

1 Nov 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

A new study explores the role of new SARS-CoV-2 variants in sustaining the pandemic in South Africa.

31 Oct 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

Largest real-world study evaluates the effectiveness of third "booster" dose of COVID-19 vaccine

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the third dose of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2.

30 Oct 2021

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

University of Utah Health scientists are leading an effort to determine if salivary glands infected with the virus that causes COVID-19 could diminish a person’s long-term immunity to the disease after being immunized or after recovering from the illness.

30 Oct 2021

Researchers decipher when and why T cells become non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

30 Oct 2021

Study: mRNA vaccines associated with more immunity than prior COVID-19 infection

A nationwide study from the Centers for Disease Control and Prevention shows that mRNA COVID-19 vaccines are associated with significantly more immunity than a prior COVID-19 infection.

29 Oct 2021

Cancer cells exploit genetic and cellular processes to promote tumor growth

Writing in EMBO reports, researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe how a pair of fundamental genetic and cellular processes are exploited by cancer cells to promote tumor survival and growth.

29 Oct 2021

UKHSA’s Green Book updated to allow flexibility in COVID-19 booster vaccines for vulnerable people

COVID-19 booster vaccines can now be given sooner than six months after their second dose to certain vulnerable people where this makes operational sense, as the UKHSA's Green Book has been updated.

29 Oct 2021

More than seven million of UK's most vulnerable people receive COVID-19 booster jabs

Over seven million of the UK's most vulnerable people have now received their COVID-19 booster jab, the latest figures show today (Friday 29 October 2021).

29 Oct 2021

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.

29 Oct 2021

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy.

28 Oct 2021

More strategic COVID-19 testing can reduce reliance on costly preventative interventions

Strategically increasing testing capacity, either by making diagnostic tests faster or more available, can reduce reliance on costly preventative interventions, such as distancing and shutdowns, according to a team of researchers led by Penn State.

28 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

How long does natural or vaccine-induced immunity to COVID last?

Researchers present a comprehensive assessment on SARS-CoV-2 induced immunity.

28 Oct 2021

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

A new study compares healthcare workers who underwent homologous Ad26.COV2.S booster vaccination to those who underwent heterologous boosting.

28 Oct 2021

Third dose of Covid-19 vaccine benefits dialysis patients

In some patients, the immune system responds poorly to the second vaccination dose. This changes with the third shot.

28 Oct 2021

immunity News and Research

More than 8 million people in the UK have taken COVID-19 booster vaccinations

The effect of mass vaccination on COVID-19 mortality in Israel

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

New Canadian serology solution for SARS-CoV-2 infections and vaccination

Largest real-world study evaluates the effectiveness of third "booster" dose of COVID-19 vaccine

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

Researchers decipher when and why T cells become non-responsive to immunotherapy

Study: mRNA vaccines associated with more immunity than prior COVID-19 infection

Cancer cells exploit genetic and cellular processes to promote tumor growth

UKHSA’s Green Book updated to allow flexibility in COVID-19 booster vaccines for vulnerable people

More than seven million of UK's most vulnerable people receive COVID-19 booster jabs

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

More strategic COVID-19 testing can reduce reliance on costly preventative interventions

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

How long does natural or vaccine-induced immunity to COVID last?

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

Third dose of Covid-19 vaccine benefits dialysis patients

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News